Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Amelenodor by AbbVie for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Amelenodor is under clinical development by AbbVie and currently in Phase I for Crohn's Disease (Regional Enteritis). According to GlobalData,...
Data Insights
Risk adjusted net present value: What is the current valuation of AbbVie's Amelenodor?
Amelenodor is a small molecule commercialized by AbbVie, with a leading Phase II program in Ulcerative Colitis. According to Globaldata,...